Aristides Capital’s iRadimed IRMD Stock Holding History

Aristides Capital’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.9M	Buy	30,083 +2,349	+8%	+$235K	0.63%	39
2025 Q4	$2.7M	Buy	27,734 +1,309	+5%	+$112K	0.48%	44
2025 Q3	$1.88M	Sell	26,425 -3,500	-12%	-$233K	0.27%	59
2025 Q2	$1.79M	Hold	29,925	–	–	0.36%	46
2025 Q1	$1.57M	Hold	29,925	–	–	0.46%	48
2024 Q4	$1.65M	Buy	29,925 +11,452	+62%	+$603K	0.34%	48
2024 Q3	$929K	Hold	18,473	–	–	0.29%	68
2024 Q2	$812K	Hold	18,473	–	–	0.23%	88
2024 Q1	$813K	Buy	18,473 +8,600	+87%	+$380K	0.3%	78
2023 Q4	$469K	Buy	9,873 +673	+7%	+$28.3K	0.17%	94
2023 Q3	$408K	Buy	+9,200	New	+$427K	0.18%	88

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristides Capital's IRMD Position: Q1 2026 in Review

Aristides Capital increased its iRadimed (IRMD) stake by 8.5% in Q1 2026, buying an estimated $235K and bringing the position to 30,083 shares worth $2.9M. The position accounts for 0.63% of the portfolio, ranked #39.

Aristides Capital first reported a position in IRMD in Q3 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Aristides Capital held 30,083 shares of iRadimed worth $2.9M as of Q1 2026.
Aristides Capital bought 2,349 iRadimed shares in Q1 2026, an estimated $235K.
iRadimed made up 0.63% of Aristides Capital's portfolio in Q1 2026, its #39 holding.
Aristides Capital first reported a position in iRadimed in Q3 2023 and has held it in 11 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.